One of my ALS symptoms is weak legs and feet, which keeps me constantly struggling to prevent further decline. Lately, I’ve been obsessed with how far I walk. Not with my ability to walk — I’ve been focused on that ever since my diagnosis in 2010 — but…
Saying no to 10,000 steps as I redefine my daily distance with ALS
Some people with amyotrophic lateral sclerosis (ALS) experience subtle signs of the disease, such as pain and motor problems, in the years before they are diagnosed. The findings add to growing evidence that ALS may have a prodromal phase, a period in which people start to experience biological changes…
People with amyotrophic lateral sclerosis (ALS) may share genetic roots with people who have other neurodegenerative conditions, including frontotemporal dementia (FTD), even when no family connection is known, a new study suggests. The findings highlight the genetic overlap across the ALS-FTD disease spectrum and suggest that conventional family histories may…
A pivotal Phase 2/3 clinical trial comparing the experimental oral therapy CB03-154 with a placebo in people with amyotrophic lateral sclerosis (ALS) has completed enrollment in China, developer Zhimeng Biopharma announced. China’s Center for Drug Evaluation (CDE) cleared the trial to begin last year. It…
We’ve had a mild fall on Michigan’s Keweenaw Peninsula with no snow or frost yet, though we often have both before November arrives. But even with our good weather, I’m steeling myself to face the coming winter. I drained my hoses and hung them on the garage wall. I picked…
President Donald Trump has signed into law legislation to renew the Accelerating Access to Critical Therapies (ACT) for amyotrophic lateral sclerosis (ALS), a federal program aimed at supporting ALS research and helping patients access promising experimental therapies. The original ACT for ALS was signed into law in 2021…
A wide range of potentially modifiable factors related to lifestyle, the environment, mental and physical health, and socioeconomic circumstances may be linked to the risk of developing amyotrophic lateral sclerosis (ALS), a study in China suggests. The researchers identified 45 factors significantly associated with ALS in an analysis of…
The ALS Society of Canada is calling on the federal government to invest CAD$50 million over five years in a national initiative aimed at accelerating research, expanding clinical trial access, and advancing the search for treatments for amyotrophic lateral sclerosis (ALS). More than 40 people living with ALS,…
The United States Congress recently passed legislation to support five more years of ALS research and expand access to promising experimental therapies. We cannot afford to waste a moment. On Sept. 28, Congress passed the Accelerating Access to Critical Therapies for ALS (ACT for ALS) Reauthorization Act, which would…
A combination of 10 blood proteins distinguished people with amyotrophic lateral sclerosis (ALS) from healthy people with 98.3% balanced accuracy in a new study. “This 10-protein combination in our ALS disease prediction model classified ALS vs control with superior accuracy … to previously published studies,” researchers wrote. However, the…
Recent Posts
- Of broken elevators and bonds: Staying connected to those we’ve lost to ALS
- Experts urge genetic testing for all ALS patients, regardless of family history
- Reflecting on the early signs of my husband’s ALS
- Experimental ALS treatment slows disease progression by 50% in trial
- ALS community to have a say in brain-computer interface development